New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
New Page: S&P500 Companies Overview
see insider trading activities and stock performance analytics over the past year - Click here
Home > AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
Industry: Life Sciences ・ $ANTX on Nasdaq ・ Market Cap: Small
CEO Recent Purchases
New Purchase Insider
Abnormal High-Volume Purchases
CEO Sales
Top Executive Sales
1Y INSIDER TRADING ACTIVITY
Insider Trade Volume in USD
1Y INSIDER ACTIVITY
| TRADES PURCHASE/SALE Sector Average | 4 / 15 2.19 / 7.65 |
| INSIDER BUYERS/SELLERS Sector Average | 4 / 7 1.2 / 2.5 |
| SHARES PURCHASED/SOLD Transaction Average | 1,775,000 / 3,846,585 443,750 / 256,439 |
| VALUE PURCHASED/SOLD Transaction Average | $1,855,000 / $10,075,386 $463,750 / $671,692 |
| PURCHASE RANGE | $25,000 - $1,560,000 |
| SALE RANGE | $4,651.2 - $3,807,101.52 |
INSIDER PERFORMANCE OVERVIEW
PURCHASE PERFORMANCE
3 / 8
CEO Purchases
Top Executive Purchases
New Purchase Insider
High Purchase Reporters Count
High Purchase Activity
Regular Purchase Insiders
Abnormal High-Volume Purchases
High Purchases Frequency
SALE PERFORMANCE
2 / 4
CEO Sales
Top Executive Sales
Regular Sale Insiders
High Sales Frequency
1Y PURCHASE DISTRIBUTION
purchase distribution by individual insiders
15.49%
DIRECTORS
0%
OFFICERS
84.51%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.644 0.2 |
VALUE GINI INDEX Sector Average | 0.644 0.206 |
1Y SALE DISTRIBUTION
sale distribution by individual insiders
5.41%
DIRECTORS
0.26%
OFFICERS
94.33%
10% OWNERS
0%
OTHERS
SHARES GINI INDEX Sector Average | 0.477 0.295 |
VALUE GINI INDEX Sector Average | 0.806 0.288 |
AN2 Therapeutics, Inc. 1Y Trade Transactions